Interventions to physicians and patients improve osteoporosis treatment at low cost. Reminding primary care doctors to test at-risk patients for osteoporosis can prevent fractures and reduce health care… read more.
EMA Highlights by Gary Finnegan – The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of marketing authorisations for several new products.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
